SCHEMBL272926

SCHEMBL272926

CC(C)CC(C)c1ccccc1NC(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
RXFP1 Q9HBX9 2/20 0.49
LMNA P02545 2/20 0.48
GAA P10253 2/20 0.48
PTPRC P08575 1/20 0.47
KCNK3 O14649 3/20 0.46
KCNK9 Q9NPC2 3/20 0.46
F2R P25116 1/20 0.46
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
PTGS1 P23219 1/20 0.44
RECQL P46063 1/20 0.44
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGES O14684 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.42
CCR8 P51685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14364829 1.00 SMN1; SMN2 (0.50) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL14364828 1.00 SMN1; SMN2 (0.50) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL5526714 0.89 SMN1; SMN2 (0.51) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL272581 0.86 SMN1; SMN2 (0.49) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL21311187 0.85 SMN1; SMN2 (0.56) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL13645646 0.85 SMN1; SMN2 (0.48) SMN1; SMN2RXFP1LMNAGAAPTPRC
SCHEMBL14364831 0.85 SMN1; SMN2 (0.40) SMN1; SMN2RXFP1LMNAGAAALDH1A1
SCHEMBL14364830 0.85 SMN1; SMN2 (0.40) SMN1; SMN2RXFP1LMNAGAAALDH1A1
SCHEMBL344457 0.85 SMN1; SMN2 (0.40) SMN1; SMN2RXFP1LMNAGAAALDH1A1
SCHEMBL14523918 0.84 LMNA (0.45) SMN1; SMN2LMNAGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104170838-A ACTIVE SUBSTANCE COMBINATIONS BAYER CROPSCIENCE AG 2014-12-03 CN claimed
US-20140213557-A1 Active Compound Combinations BAYER CROPSCIENCE AG (DE) 2014-07-31 US claimed
CN-103814900-A Active substance combinations BAYER CROPSCIENCE AG 2014-05-28 CN claimed
CN-103548836-A Synergistic active substance combinations containing phenyl triazoles BAYER CROPSCIENCE AG 2014-02-05 CN claimed
EP-2364592-A1 Synergetic fungicide substance combinations Bayer Cropscience AG (DE) 2011-09-14 EP claimed
EP-2356905-A1 Synergetic fungicide substance combinations Bayer Cropscience AG (DE) 2011-08-17 EP claimed
EP-2356906-A1 Synergetic fungicide substance combinations Bayer Cropscience AG (DE) 2011-08-17 EP claimed
US-20110152097-A1 Active Compound Combinations BAYER CROPSCIENCE AG (DE) 2011-06-23 US claimed
EP-2255651-A2 Agent combinations Bayer CropScience AG (DE) 2010-12-01 EP claimed
EP-2255644-A2 Agent combinations Bayer CropScience AG (DE) 2010-12-01 EP claimed
EP-1796468-A1 SYNERGISTIC FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS WHICH CONTAIN SPIROXAMINE, A TRIAZOLE AND A CARBOXAMIDE Bayer CropScience AG (DE) 2007-06-20 EP claimed
JP-2007509088-A 2007-04-12 JP claimed
WO-2006131221-A2 CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2006-12-14 WO claimed
WO-2006105889-A2 SYNERGISTIC FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-10-12 WO claimed
US-20060211771-A1 Phenyl benzamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-09-21 US claimed
EP-1677598-A2 SYNERGISTIC FUNGICIDAL ACTIVE COMBINATIONS Bayer CropScience Aktiengesellschaft (DE) 2006-07-12 EP claimed
WO-2006032356-A1 SYNERGISTIC FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS WHICH CONTAIN SPIROXAMINE, A TRIAZOLE AND A CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2006-03-30 WO claimed
WO-2005041653-A2 SYNERGISTIC FUNGICIDAL ACTIVE COMBINATIONS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-05-12 WO claimed
EP-1519913-A1 PHENYL BENZAMIDES Bayer CropScience AG (DE) 2005-04-06 EP claimed
WO-2004005242-A1 PHENYL BENZAMIDES BAYER CROPSCIENCE AG (DE) 2004-01-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152097-A1 Active Compound Combinations AGXT, GLUL, GMNN SMN1; SMN2 3746/4885RXFP1 3254/4885LMNA 3752/4885
US-20140213557-A1 Active Compound Combinations AGXT, GLUL, GMNN SMN1; SMN2 3746/4885RXFP1 3254/4885LMNA 3752/4885
US-20060211771-A1 Phenyl benzamides PADI1, PNMT, BRPF3 SMN1; SMN2 4447/4885RXFP1 2560/4885LMNA 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.